146 related articles for article (PubMed ID: 15988687)
1. Redefining bronchioloalveolar carcinoma.
Laskin JJ; Sandler AB; Johnson DH
Semin Oncol; 2005 Jun; 32(3):329-35. PubMed ID: 15988687
[TBL] [Abstract][Full Text] [Related]
2. Bronchoalveolar carcinoma: current treatment and future trends.
Laskin JJ
Clin Lung Cancer; 2004 Dec; 6 Suppl 2():S75-9. PubMed ID: 15638963
[TBL] [Abstract][Full Text] [Related]
3. Emerging approaches to advanced bronchioloalveolar carcinoma.
West H
Curr Treat Options Oncol; 2006 Jan; 7(1):69-76. PubMed ID: 16343370
[TBL] [Abstract][Full Text] [Related]
4. Bronchioloalveolar carcinoma: a review.
Raz DJ; He B; Rosell R; Jablons DM
Clin Lung Cancer; 2006 Mar; 7(5):313-22. PubMed ID: 16640802
[TBL] [Abstract][Full Text] [Related]
5. Systemic therapy of bronchioloalveolar carcinoma: results of the first IASLC/ASCO consensus conference on bronchioloalveolar carcinoma.
Kris MG; Giaccone G; Davies A; Fukuoka M; Garfield DH; Jassem J; Quoix EA; Sandler AB; Scagliotti GV; Van Meerbeeck JP; West H
J Thorac Oncol; 2006 Nov; 1(9 Suppl):S32-6. PubMed ID: 17409999
[TBL] [Abstract][Full Text] [Related]
6. Bronchioloalveolar carcinoma and lung adenocarcinoma: the clinical importance and research relevance of the 2004 World Health Organization pathologic criteria.
Travis WD; Garg K; Franklin WA; Wistuba II; Sabloff B; Noguchi M; Kakinuma R; Zakowski M; Ginsberg M; Padera R; Jacobson F; Johnson BE; Hirsch F; Brambilla E; Flieder DB; Geisinger KR; Thunnissen F; Kerr K; Yankelevitz D; Franks TJ; Galvin JR; Henderson DW; Nicholson AG; Hasleton PS; Roggli V; Tsao MS; Cappuzzo F; Vazquez M
J Thorac Oncol; 2006 Nov; 1(9 Suppl):S13-9. PubMed ID: 17409995
[TBL] [Abstract][Full Text] [Related]
7. Systemic therapy of advanced bronchioloalveolar cell carcinoma: challenges and opportunities.
Miller VA; Hirsch FR; Johnson DH
J Clin Oncol; 2005 May; 23(14):3288-93. PubMed ID: 15886316
[TBL] [Abstract][Full Text] [Related]
8. Pathology of human bronchioloalveolar carcinoma and its relationship to the ovine disease.
Mornex JF; Thivolet F; De las Heras M; Leroux C
Curr Top Microbiol Immunol; 2003; 275():225-48. PubMed ID: 12596901
[TBL] [Abstract][Full Text] [Related]
9. The impact of cigarette smoking on prognosis in small adenocarcinomas of the lung: the association between histologic subtype and smoking status.
Sakao Y; Miyamoto H; Oh S; Takahashi N; Inagaki T; Miyasaka Y; Akaboshi T; Sakuraba M
J Thorac Oncol; 2008 Sep; 3(9):958-62. PubMed ID: 18758296
[TBL] [Abstract][Full Text] [Related]
10. [Bronchiolar-alveolar carcinoma: From concept to innovative therapeutic strategies].
Wislez M; Lavolé A; Gounant V; Antoine M; Cadranel J
Presse Med; 2011 Apr; 40(4 Pt 1):389-97. PubMed ID: 21419590
[TBL] [Abstract][Full Text] [Related]
11. Rising incidence of bronchioloalveolar lung carcinoma and its unique clinicopathologic features.
Barsky SH; Cameron R; Osann KE; Tomita D; Holmes EC
Cancer; 1994 Feb; 73(4):1163-70. PubMed ID: 8313318
[TBL] [Abstract][Full Text] [Related]
12. The bronchioloalveolar carcinoma and peripheral adenocarcinoma spectrum of diseases.
Garfield DH; Cadranel JL; Wislez M; Franklin WA; Hirsch FR
J Thorac Oncol; 2006 May; 1(4):344-59. PubMed ID: 17409882
[TBL] [Abstract][Full Text] [Related]
13. Bronchioloalveolar carcinoma: a review of the epidemiology, pathology, and treatment.
Jackman DM; Chirieac LR; Jänne PA
Semin Respir Crit Care Med; 2005 Jun; 26(3):342-52. PubMed ID: 16052436
[TBL] [Abstract][Full Text] [Related]
14. High incidence of EGFR mutations in Korean men smokers with no intratumoral heterogeneity of lung adenocarcinomas: correlation with histologic subtypes, EGFR/TTF-1 expressions, and clinical features.
Sun PL; Seol H; Lee HJ; Yoo SB; Kim H; Xu X; Jheon S; Lee CT; Lee JS; Chung JH
J Thorac Oncol; 2012 Feb; 7(2):323-30. PubMed ID: 22237264
[TBL] [Abstract][Full Text] [Related]
15. A new era for bronchioloalveolar carcinoma: current state of the art and recent advances in biologically targeted therapy.
Johal BS; Laskin J
Expert Rev Anticancer Ther; 2006 Oct; 6(10):1411-9. PubMed ID: 17069526
[TBL] [Abstract][Full Text] [Related]
16. Molecular characteristics of bronchioloalveolar carcinoma and adenocarcinoma, bronchioloalveolar carcinoma subtype, predict response to erlotinib.
Miller VA; Riely GJ; Zakowski MF; Li AR; Patel JD; Heelan RT; Kris MG; Sandler AB; Carbone DP; Tsao A; Herbst RS; Heller G; Ladanyi M; Pao W; Johnson DH
J Clin Oncol; 2008 Mar; 26(9):1472-8. PubMed ID: 18349398
[TBL] [Abstract][Full Text] [Related]
17. The epidemiology of bronchioloalveolar carcinoma over the past two decades: analysis of the SEER database.
Read WL; Page NC; Tierney RM; Piccirillo JF; Govindan R
Lung Cancer; 2004 Aug; 45(2):137-42. PubMed ID: 15246183
[TBL] [Abstract][Full Text] [Related]
18. BAC consensus conference, November 4-6, 2004: epidemiology, pathogenesis, and preclinical models.
Christiani DC; Pao W; DeMartini JC; Linnoila RI; Malkinson AM; Onn A; Politi KA; Sharp M; Wong KK
J Thorac Oncol; 2006 Nov; 1(9 Suppl):S2-7. PubMed ID: 17409996
[TBL] [Abstract][Full Text] [Related]
19. Bronchioloalveolar carcinoma of the lung 3 centimeters or less in diameter: a prognostic assessment.
Sakurai H; Dobashi Y; Mizutani E; Matsubara H; Suzuki S; Takano K; Shindo S; Matsumoto M
Ann Thorac Surg; 2004 Nov; 78(5):1728-33. PubMed ID: 15511463
[TBL] [Abstract][Full Text] [Related]
20. Systemic approaches for multifocal bronchioloalveolar carcinoma: is there an appropriate target?
Levy BP; Drilon A; Makarian L; Patel AA; Grossbard ML
Oncology (Williston Park); 2010 Sep; 24(10):888-98, 900. PubMed ID: 21138169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
